ACTINIUM PHARMACEUTICALS, INC. Increase (Decrease) in Notes Payable, Current
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Increase (Decrease) in Notes Payable, Current of $0 for the 12-month period ending 2011-12-31, per its 10-K filed 2012-04-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInNotesPayableCurrent · last filed 2012-04-12
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in notes payable, current for fiscal 2011 was $0.00.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in notes payable, current for fiscal 2010 was $0.00.
| Period end | Increase (Decrease) in Notes Payable, Current 12 month |
|---|---|
| 2011-12-31 | $0.00 10-K · filed 2012-04-12 |
| 2010-12-31 | $0.00 10-K · filed 2012-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |